Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Weiland Robert J.
Chief Commercial Officer
Transactions
- Award
Common Stock
2017-06-14+4,500→ 4,864 total - Award
Stock Option (Right to Buy)
2017-06-14+9,000→ 9,000 totalExercise: $44.20Exp: 2027-06-14→ Common Stock (9,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]Includes 364 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016.
- [F3]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.